期刊名称：JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The Journal of Pediatric Hematology/Oncology reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. Each issue presents informative case studies and original research articles from leading clinicians and investigators worldwide. Also featured are specially developed Continuing Seminars, which serve the continuing education needs of physicians by offering new insights into many areas of interest, as well as analyses of radiological problems in pediatric hematology/oncology and discussions of pertinent ethical and legal issues.
In Every Issue of JPH/O...
- Original, peer-reviewed articles
- Case reports
- Continuing seminars
- Book reviews
|
|
Instructions to Authors
Address for manuscript submission
Send 1 original and 3 copies of the manuscript and 3 sets of illustrations to:
Robert J. Arceci, MD, PhD
Editor-in-Chief
Journal of Pediatric Hematology/Oncology
Director Pediatric Oncology
Johns Hopkins Oncology Center
Bunting-Blaustein Cancer Research Building
1650 Orleans Street, 2M51
Baltimore, MD 21231
Tel: (410) 502-7519
E-mail: arcecro@jhmi.edu
(please see the checklist at the end of these Instructions before mailing manuscripts). A cover letter should include mailing address, telephone and fax numbers, and e-mail address of the responsible author. Indicate name and address of author to whom proofs and reprint requests are to be sent. If color figures are included with the manuscript, please request a color figure reproduction estimate or request black-and-white conversion. The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for reference. Address all inquiries regarding manuscripts not yet accepted or published to the Journal's editorial office. The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for reference.
Manuscript Submission
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: All authors must sign a copy of the journal's Authorship Responsibility, Financial Disclosure, and Copyright Transfer form and submit it with the original manuscript.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
General format: Submit manuscripts in English in triplicate (one original and three copies) and printed on standard 8??11-inch (21 ?28-cm) paper with at least a 1-inch (2.5 cm) margin on all sides. Double space all copy, including legends, footnotes, tables, and references, and print on one side of the sheet only. If a manuscript is accepted for publication, the authors must then submit the final, accepted version of the manuscript on disk.
Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment. If an article has more than six authors, adequate justification should be provided to the Editorial Office along with the contributions of the authors.
Structured abstract and key words: Limit the abstract to 250 words. Do not cite references in the abstract. Limit the use of abbreviations and acronyms. Use the following subheads: Purpose, Methods (or Materials and Methods or Patients and Methods), Results, Conclusions, and Key Words. List three to five key words.
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods (or Patients and Methods, corresponding with abstract head), Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at: http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Farkas LG, Tompson B, Phillips JH, et al. Comparison of anthropometric and cephalometric measurements of the adult face. J Craniofacial Surg 1999;10:18?5.
Book chapter
2. Todd VR. Visual information analysis: Frame of reference for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy Philadelphia: Lippincott Williams & Wilkins, 1999:205?6.
Entire book
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation Philadelphia: Lippincott Williams & Wilkins, 1999.
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22?7. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Figures: Cite figures consecutively in the text, and number them in the order in which they are discussed. Write the first author's last name, the figure number and figure part (1A, 1B, 1C), and an arrow to indicate the top edge of the figure on a label pasted to the back of each figure. Submit all artwork in triplicate in camera-ready form; illustrations should be glossy prints or high-quality, laser-printed illustrations. Photocopies are unacceptable. Lettering should be large enough that it will remain legible after figure reduction; typewritten or unprofessional lettering is unacceptable. Figure parts (A, B, C) may be left unlabeled (but clearly marked on back) for professional placement by the Journal's printer.
Figure legends: Legends must be submitted for all figures. They should be brief and specific, typed, double-spaced and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Digital figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs?radiographs, CT scans, and so on?and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Files can be submitted on a 3?inch high-density disk, a CD-ROM, or an Iomega Zip disk. Please note that artwork generated from office suite programs such Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used.
Tables: Cite tables consecutively in the text, and number them in order. Each table should be typed, double-spaced on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
CLINICAL AND LABORATORY OBSERVATIONS
Clinical observations may include case histories that demonstrate novel findings or associations, important clinical responses when a larger study is not needed to address a specific issue, or a unique laboratory observation linked to clinical care and/or practice. Text should contain 2500 words or fewer, with a brief abstract of 100 words or fewer. Abstracts outline background, observation(s), and conclusions. Include 4 illustrations and/or tables or fewer and 20 references or fewer.
MEDICAL PROGRESS
Review articles for this section should highlight what is particularly new and novel in a field related to pediatric hematology/oncology. Text should contain 5000 words or fewer and 100 references or fewer. Shorter reviews are encouraged and preferred. Authors considering submission should consult the Editor-in-Chief.
MORPHOLOGY CORNER
This section features photographs of especially interesting blood smears, bone marrow, or other tissue specimens that highlight an important aspect of hematology/oncology. Include an introduction of 200 words or fewer, the figure(s), a conclusion of 200 words or fewer, and 6 references or fewer.
RADIOLOGY CORNER
This section features photographs of scans of radiographic studies, such as plain radiographs, bone scans, computed tomography scans, magnetic resonance images, or other modalities highlighting a special feature of a topic or case. Include an introduction of 200 words or fewer, the figure(s), a conclusion of 200 words or fewer, and 6 references or fewer.
HISTORICAL INSIGHTS
Historical insights include concise descriptions or analyses of historical importance in the field of pediatric hematology/oncology. These may include personal descriptions of historical figures, important papers, and interesting occurrences that led to advancements in pediatric hematology/oncology. Photographs and artwork are welcome. Text should contain 2500 words or fewer and include 25 references or fewer. All material should be original or carry permission for publication.
LETTERS TO THE EDITOR
Letters to the editor should pertain to articles published within the Journal of Pediatric Hematology/Oncology or highlight important new clinical or laboratory insights. Text should contain 500 words or fewer.
BOOK REVIEWS
Reviews of books should relate to topics relevant to pediatric hematology/oncology, including immunology and transplantation. Text should contain 1000 words or fewer.
ANNOUNCEMENTS
Announcements should be submitted 6 months in advance of the event date and may include scheduled meetings, symposia, postgraduate courses, and other announcements of interest to specialists in pediatric hematology/oncology.
After Acceptance
Disk submission: Authors must submit an electronic version of the final accepted manuscript along with a printout of the final accepted manuscript. Electronic files should be submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files. Do not use automatic numbering or footnotes for references. The Journal does not assume responsibility for errors in the conversion of customized software, newly released software, and special characters. Authors preparing manuscripts on Macintosh computers should not use the Fast Save option. Each submitted disk must be clearly labeled with the name of the author, item title, journal title, word processing program and version, and file name used. The disk should contain only the final version of the accepted manuscript.
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any questions.
Publisher's contact: Fax corrected page proofs, reprint order forms, and any other related materials to Proof Manager, Journal of Pediatric Hematology/Oncology, 717-633-8928. Color proofs should be returned to the Proof Managaer, The Sheridan Press, 450 Fame Avenue, Hanover, PA 17331.
Manuscript Checklist To top of page
- Four copies of complete manuscript
- Four sets of clearly labeled figures
- Cover letter
- Title page
- Abstract and keywords
- References double-spaced in AMA style
- Corresponding author designated (in cover letter and on title page)
- E-mail address of corresponding author included in cover letter and on title page
- Permission to reproduce copyrighted materials or signed patient consent forms
- Acknowledgments listed for grants and technical support
- Materials packed in extra-strength envelope
- Manuscript Authorship Responsibility, Financial Disclosure, and Copyright Transfer form signed by each author
- Disk and high-quality print of electronic art
- Disk containing final version of manuscript after acceptance by editorial office
Editorial Board
| The Journal of Pediatric Hematology/Oncology (JPH/O) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. Each issue presents informative case studies and original research articles from leading clinicians and investigators worldwide. Also featured are specially developed Continuing Seminars, which serve the continuing education needs of physicians by offering new insights into many areas of interest, as well as analyses of radiological problems in pediatric hematology/oncology and discussions of pertinent ethical and legal issues. |
| |
|
| |
Business Correspondence
Publisher
David Myers
dmyers@lww.com
Business Offices
Lippincott Williams & Wilkins
530 Walnut Street
Philadelphia, PA 19016
Phone: 215-521-8300
http://www.lww.com
|
|
Editorial Correspondence
Editor-in-Chief
Robert J. Arceci, M.D., Ph.D.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1650 Orleans St. 2M51
Baltimore, MD 21231
Tel: (410) 502-7519
Fax: (410) 502-7233
E-mail: arcecro@jhmi.edu
|
| |
|
刊名字顺( Alphabetical List of Journals):
返回页首 